Seroepidemiology of hepatitis A virus in children of different age groups in Tehran, Iran: Implications for health policy

Travel Medicine and Infectious Disease

Volumn 8, Issue 3, 2010, Pages 176-179

  Sofian, Masoomeh ^a   Aghakhani, Arezoo ^b   Farazi, Ali Asghar ^a   Banifazl, Mohammad ^c   Etemadi, Gelavizh ^d   Azad Armaki, Saeed ^e   Ziazarifi, Abolhassan ^f   Abhari, Zohreh ^g   Eslamifar, Ali ^b   Khadem Sadegh, Akbar ^b   Izadi, Nabiallah ^h   Ramezani, Amitis ^b  

^a ARAK UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b PASTEUR INSTITUTE OF IRAN   (Iran)

^c Iranian Society for Support of Patients with Infectious Diseases   (Iran)

^d Chamran Hospital   (Iran)

^e Khatamolanbia Hospital   (Iran)

^f SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^g Madaen Hospital   (Iran)

^h IRANIAN BLOOD TRANSFUSION ORGANIZATION   (Iran)

Author keywords

Children; Hepatitis A virus (HAV); Seroepidemiology

Indexed keywords

HEPATITIS A ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GROUPS BY AGE; HEALTH CARE POLICY; HEPATITIS A; HEPATITIS A VIRUS; HUMAN; INFANT; IRAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SEROEPIDEMIOLOGY; SEROPREVALENCE; BLOOD; CHI SQUARE DISTRIBUTION; IMMUNOLOGY;

ADOLESCENT; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH POLICY; HEPATITIS A; HEPATITIS A ANTIBODIES; HEPATITIS A VIRUS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT; IRAN; MALE; YOUNG ADULT;

EID: 77957266144     PISSN: 14778939     EISSN: 18730442     Source Type: Journal    
DOI: 10.1016/j.tmaid.2010.02.004     Document Type: Article

References (20)

1. Cuthbert JA. Hepatitis A. Old and new. Clin Microb Rev 2001; 14:38-58.
2. Jacobsen KH, Koopman JS. Declining hepatitis A seropreva-lence: a global review and analysis. Epidemiol Infect 2004; 132:1005-22. (Pubitemid 39642381)
3. World Health Organization (WHO). Department of communicable disease surveillance and response. Hepatitis A. WHO/CDS/CSR/EDC/2000.7.
4. Foussal MD, Picon C, Sorrentino A. Hepatitis A in childhood. The tip of an infectious disease iceberg. Acta Gastroenterol Latinoam 2002;32:101-5.
5. Tufenkeji H. Hepatitis A shifting epidemiology in Middle East and Africa. Vaccine 2000;18:65-7.
6. Quaglio G, Ramadani N, Pattaro C, Cami A, Dentico P, Volpe A, et al. Prevalence and risk factors for viral hepatitis in the Kosovarian population: implications for health policy. J Med Virol 2008;80(5):833-40. (Pubitemid 351500031)
7. Kaya D, Guler E, Ekerbicer HC, Dilber C, Karabiber H, Guler S, et al. Hepatitis A seroprevalence and its relationship with environmental factors in children of different age groups in Kahramanmaras, Eastern Mediterranean region of Turkey. J Viral Hepat 2007;14(12):830-4. (Pubitemid 350211413)
8. Innis BL, Snitbhan R, Kunasol P, Laorakpongse T, Poopatanakool W, Kozik CA, et al. Protection against hepatitis A by an inactivated vaccine. JAMA 1994;271:1328-34. (Pubitemid 24132458)
9. Srinivasa Rao AS, Chen MH, Pham BZ, Tricco AC, Gilca V, Duval B, et al. Cohort effects in dynamic models and their impact on vaccination programmes: an example from hepatitis A. BMC Infect Dis 2006;6:174.
10. Hepatitis. A vaccines. WHO position paper. Wkly Epidemiol Rec 2000;75:38-43.
11. Lavanchy D. Viral hepatitis: global goals for vaccination. J Clin Virol; 2009 [Epub ahead of print].
12. Gust ID. Epidemiological patterns of hepatitis A in different parts of the world. Vaccine 1992;10:56-8.
13. Tufenkeji H. Hepatitis A shifting epidemiology in the Middle East and Africa. Vaccine 2000;18(Suppl. 1):S65-S67. (Pubitemid 30100470)
14. Ahmed M, Munshi SU, Nessa A, Ullah MS, Tabassum S, Islam MN. High prevalence of hepatitis A virus antibody among Bangladeshi children and young adults warrants pre-immunization screening of antibody in HAV vaccination strategy. Indian J Med Microbiol 2009;27(1):48-50.
15. Acharya SK, Batra Y, Bhatkal B, Ojha B, Kaur K, Hazari S, et al. Seroepidemiology of hepatitis A virus infection among school children in Delhi and north Indian patients with chronic liver disease: implications for HAV vaccination. J Gastroenterol Hepatol 2003;18(7):822-7. (Pubitemid 36936575)
16. Barzaqua BN. Hepatitis A shifting epidemiology in South-East and China. Vaccine 2000;(Suppl. 18):S61eS64.
17. Mathur P, Arora NK. Epidemiological transition of hepatitis A in India: issues for vaccination in developing countries. Indian J Med Res 2008;128(6):699-704.
18. Mehr AJ, Ardakani MJ, Hedayati M, Shahraz S, Mehr EJ, Zali MR. Age-specific seroprevalence of hepatitis A infection among children visited in pediatric hospitals of Tehran, Iran. Eur J Epidemiol 2004;19(3):275-8. (Pubitemid 38461690)
19. Saberifiroozi M. Prevention of hepatitis A infection. Hep Mon 2005;5(1):19-27.
20. Roushan MR, Bijani A, Sagheb R, Jazayeri O. Prevalence of hepatitis A IgG in individuals with chronic hepatitis B infection in Babol. East Mediterr Health J 2007;13(5): 1108-13.